COMMD10 and gastric cancer: To determine whether COMMD10 expression affects patient survival, GC patients were divided into a high COMMD10 expression group (the top 50% of the highest expression samples) and a low COMMD10 expression group (the remaining 50% of samples) using the GEPIA database.